Use of Technology and Telemedicine to Improve Quality of Care in COVID 19 Patients
Primary Purpose
Diagnoses Disease, Covid19
Status
Withdrawn
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Doctorgram Patient Kit
Sponsored by
About this trial
This is an interventional other trial for Diagnoses Disease focused on measuring Telemedicine
Eligibility Criteria
Inclusion Criteria:
- Hospitalized patient with COVID 19 or outpatient under investigation for or diagnosed with COVID 19
- Clinically stable (on 4L O2 or less, non ICU)
- Demonstrates ability to be trained in use of digital stethoscope technology
Exclusion Criteria:
- Pregnancy
- Delirium
Sites / Locations
- Stanford University
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
COVID-19 Patients
Arm Description
Patients that are admitted to the hospital with COVID 19.
Outcomes
Primary Outcome Measures
Patient provider experience survey score
Five questions related to satisfaction with experience using home pulse oximetry, each on a scale of 1 (poor) to 5 (excellent) summed and averaged for an overall range of 1 to 5 (higher scores = better experience).
Provider experience survey score
Four questions related to satisfaction with experience using home pulse oximetry, each on a scale of 1 (poor) to 5 (excellent) summed and averaged for an overall range of 1 to 4 (higher scores = better experience).
Use of personal protective improvement
Level of personal protective improvement in an in-patient setting.
Number of in-patient encounters with COVID patients as a measure of provider exposure to high risk illness
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT04480411
Brief Title
Use of Technology and Telemedicine to Improve Quality of Care in COVID 19 Patients
Official Title
Use of Technology and Telemedicine to Improve Quality of Care in COVID 19 Patients
Study Type
Interventional
2. Study Status
Record Verification Date
January 2022
Overall Recruitment Status
Withdrawn
Why Stopped
Unavailable IT resources
Study Start Date
January 2022 (Anticipated)
Primary Completion Date
December 2022 (Anticipated)
Study Completion Date
December 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Stanford University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to assess the use of technology including remote vital sign monitoring in improving quality of patient care, decreasing hospital admissions and re-admissions, decreasing hospital length of stay and decreasing use of personal protective equipment.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diagnoses Disease, Covid19
Keywords
Telemedicine
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Arm Title
COVID-19 Patients
Arm Type
Experimental
Arm Description
Patients that are admitted to the hospital with COVID 19.
Intervention Type
Behavioral
Intervention Name(s)
Doctorgram Patient Kit
Intervention Description
Participants will use the Doctorgram Patient Kit for remote monitoring and remote use stethoscope.
Primary Outcome Measure Information:
Title
Patient provider experience survey score
Description
Five questions related to satisfaction with experience using home pulse oximetry, each on a scale of 1 (poor) to 5 (excellent) summed and averaged for an overall range of 1 to 5 (higher scores = better experience).
Time Frame
Once after completion of device use (up to 15 minutes to complete the survey)
Title
Provider experience survey score
Description
Four questions related to satisfaction with experience using home pulse oximetry, each on a scale of 1 (poor) to 5 (excellent) summed and averaged for an overall range of 1 to 4 (higher scores = better experience).
Time Frame
Once after completion of device use (up to 15 minutes to complete the survey)
Title
Use of personal protective improvement
Description
Level of personal protective improvement in an in-patient setting.
Time Frame
6 months
Title
Number of in-patient encounters with COVID patients as a measure of provider exposure to high risk illness
Time Frame
6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Hospitalized patient with COVID 19 or outpatient under investigation for or diagnosed with COVID 19
Clinically stable (on 4L O2 or less, non ICU)
Demonstrates ability to be trained in use of digital stethoscope technology
Exclusion Criteria:
Pregnancy
Delirium
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ritu Parikh, MD
Organizational Affiliation
Stanford University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Julieta M Gabiola, MD
Organizational Affiliation
Stanford University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Nicholas Scoulios, MD
Organizational Affiliation
Stanford University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Lisa Shieh, MD
Organizational Affiliation
Stanford University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Stanford University
City
Stanford
State/Province
California
ZIP/Postal Code
94305
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Use of Technology and Telemedicine to Improve Quality of Care in COVID 19 Patients
We'll reach out to this number within 24 hrs